相关实验视频
Updated: Jun 7, 2025

08:10
The 6-hydroxydopamine Rat Model of Parkinson's Disease
Published on: October 27, 2021
10.6K
帕金森病亚型:方法和临床影响
Xiao Deng1, Anish Mehta2, Bin Xiao1
1National Neuroscience Institute, Parkinson Foundation International Centre of Excellence, Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore.
Parkinsonism & related disorders
|November 20, 2024
概括
识别帕金森病 (PD) 亚型对于个性化治疗至关重要. 本综述探讨了基于假设和数据的方法,以更好地了解PD异质性,并指导未来的治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 临床研究 临床研究
背景情况:
- 帕金森病 (PD) 在表现和进展方面表现出显著的异质性.
- 鉴定亚型是PD研究的关键优先事项,以改善患者管理.
- 现有的亚型包括假设驱动 (例如,运动) 和新兴的非运动症状 (NMS) 亚型,如轻度认知障碍 (MCI).
研究的目的:
- 审查和总结各种PD亚型的特征,从假设驱动到数据驱动的方法.
- 突出目前NMS和数据驱动PD亚型化中的理解和知识差距.
- 强调未来需要基于生物标志物进行针对性治疗和预后的亚型化.
主要方法:
- 关于帕金森病亚型的现有文献的综述.
- 基于假设 (预先定义的标准) 和基于数据 (全面的多维数据评估) 的分类方法的比较.
- 对不同PD亚型的特征和当前理解的分析.
主要成果:
- 由假设驱动的子类型,特别是运动子类型,已经得到了很好的确立.
- 非运动性症状 (NMS) 和数据驱动子类型的理解较少,特别是在生物标志物和进展方面.
- 目前的分类方法需要进一步开发,以便在早期预测和个性化治疗.
结论:
- 准确的PD亚型确定对于个性化医学,预后和临床试验设计至关重要.
- 未来的研究应该集中在数据驱动和基于生物标志物的亚型化上,以阐明潜在的病理生理学.
- 开发早期PD亚型算法将使得有针对性的治疗和积极的并发症预防成为可能.
相关概念视频
Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
Parkinson's Disease: Treatment
220
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
220
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K

